Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CREEK is a Multicenter Retrospective Study to Understand the Clinical Characteristics, Treatment Pathway and Resource Utilization for Patients With Chronic Lymphocytic Leukemia in International Region.

NCT04964908 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04964908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04964908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CREEK is a Multicenter Retrospective Study to Understand the Clinical Characteristics, Treatment Pathway and Resource Utilization for Patients With Chronic Lymphocytic Leukemia in International Region.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
December 3, 2021
Completion date
August 31, 2023
Enrollment
1,088 (actual)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia